Today, Robinhood Ventures Fund II (RVII) announced the launch of the roadshow for its initial public offering of common shares of beneficial interest.

RVII has filed a registration statement on Form N-2 with the U.S. Securities and Exchange Commission to offer up to 8,000,000 common shares of beneficial interest at an expected initial public offering price of $25 per share.

The offering consists of up to 7,600,000 common shares of beneficial interest being offered by RVII and up to 400,000 common shares of beneficial interest being offered by Robinhood Markets, Inc. (the “Selling Shareholder”). The window to request IPO shares is expected to close on August 12. RVII will not receive any of the proceeds from the sale of shares by the Selling Shareholder.

In addition, RVII intends to grant the underwriters a 30-day option to purchase up to an additional 1,200,000 common shares of beneficial interest from RVII at the same price as the initial offering price, less underwriting discounts and commissions. The shares are expected to be listed on the New York Stock Exchange (NYSE) under the symbol RVII.

Goldman Sachs & Co. LLC is the lead bookrunner for the proposed offering. Citigroup, J.P. Morgan, UBS Investment Bank, and Wells Fargo Securities are joint bookrunners for the proposed offering.

A registration statement relating to the proposed sale of common shares of beneficial interest of Robinhood Ventures Fund II has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

The proposed offering by Robinhood Ventures Fund II (“RVII”) will be made only by means of a prospectus, which forms part of the registration statement.